The Fed is expected to move forward with a quarter-point rate cut on Wednesday. Fed observers will be watching to see what ...
A major earnings reset and fresh fund interest could mark a turning point for this formerly high-flying life-sciences stock.
Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate update and reported financial results for the third quarter ended September 30, 2025. "Our third quarter demonstrated exceptional ...